Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (1)

1998

  1. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A: Implications for drug-drug interactions and pharmacological activity of the main metabolite

    Drug Metabolism and Disposition, Vol. 26, Núm. 8, pp. 802-811